Fool.com Headlines: Cubist Receives Antitrust Clearance for Trius Purchase

Fool.com Headlines Fool.com Headlines

Madesmith Modern handmade. New designers every week. From our sponsors

Cubist Receives Antitrust Clearance for Trius Purchase Aug 30th 2013, 02:08, by Rich Duprey, The Motley Fool Biopharmaceutical initiated cash tender offer to buy rival for $13.50 per share.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions